AstraZeneca cancels £450m plant in UK after Authorities 'personal purpose'

0
10
AstraZeneca cancels £450m plant in UK after Authorities 'personal purpose'


Mr Hancock instructed the Covid Inquiry, earlier in January, that Britain’s vaccine manufacturing capability was “weak”, including: “having that manufacture and fill and end onshore, bodily throughout the UK, is essential in the best way that it merely isn’t in regular instances”.


Supply hyperlink